Sen. Bernie Sanders (I-Vt.) on Wednesday blasted Novo Nordisk for the “outrageously high price” of its blockbuster type 2 diabetes drug Ozempic (semaglutide) and called on the company to lower costs for the treatment as well as the weight-loss medication Wegovy, which has the same active ingredient.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,